Company intelligence / Profile preview

Parx Materials

Rotterdam, South Holland, Netherlands

Ownership: Private
Development stage: Other

Overview

Parx Materials’ patented Passive Action Polymer Technology™ is effective (>99%) at preventing microbial adhesion and biofilm formation on surfaces; certified via ISO 22196 in multiple independent labs; technology is non-toxic, biocompatible, does not leach, and is suitable for healthcare and food-contact uses

Therapeutic areas: Infectious Diseases
Modalities: PolymerDeviceBiologic
Industry: Chemicals & Materials

Partnerships

Research collaborations with leading chemical universities in Europe and accredited testing labs

Beyond the preview

Go deeper on Parx Materials.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Parx Materials.

Explore the full profile